Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Non Operating Income: 2017-2024

Historic Non Operating Income for Northwest Biotherapeutics (NWBO) over the last 8 years, with Dec 2024 value amounting to -$17.3 million.

  • Northwest Biotherapeutics' Non Operating Income fell 173.54% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 289.66%. This contributed to the annual value of -$17.3 million for FY2024, which is 143.55% down from last year.
  • Per Northwest Biotherapeutics' latest filing, its Non Operating Income stood at -$17.3 million for FY2024, which was down 143.55% from -$7.1 million recorded in FY2023.
  • In the past 5 years, Northwest Biotherapeutics' Non Operating Income ranged from a high of $231.8 million in FY2021 and a low of -$443.2 million during FY2020.
  • Over the past 3 years, Northwest Biotherapeutics' median Non Operating Income value was -$17.3 million (recorded in 2024), while the average stood at -$20.7 million.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Non Operating Income slumped by 6,284.12% in 2020, and later soared by 152.31% in 2021.
  • Over the past 5 years, Northwest Biotherapeutics' Non Operating Income (Yearly) stood at -$443.2 million in 2020, then skyrocketed by 152.31% to $231.8 million in 2021, then plummeted by 116.33% to -$37.9 million in 2022, then surged by 81.27% to -$7.1 million in 2023, then tumbled by 143.55% to -$17.3 million in 2024.